The "Insulin Antibodies Highly Sensitive Test" is a specialized diagnostic procedure designed to detect antibodies against insulin in the blood. These antibodies can interfere with insulin action or with insulin measurements in individuals, potentially leading to conditions such as insulin resistance or autoimmune diabetes. The presence of insulin antibodies is a critical marker for understanding various diabetes-related conditions and can help in the management and treatment of patients, especially those who might be experiencing unusual blood glucose levels or have a history of autoimmune diseases.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic solutions, this test offers a highly sensitive approach to detecting even low levels of insulin antibodies. Utilizing state-of-the-art technology, DNA Labs ensures precise and reliable results, contributing significantly to patient care and management strategies.
The cost of the Insulin Antibodies Highly Sensitive Test at DNA Labs UAE is set at 2010 AED. This investment covers the sophisticated techniques and equipment required to accurately identify the presence and levels of insulin antibodies, providing essential insights for healthcare providers. Patients and doctors considering this test can expect a thorough analysis, which is crucial for developing an effective treatment plan for conditions influenced by insulin antibodies.
The Tryptophan Quantitative Plasma Test is a specialized diagnostic procedure designed to accurately measure the concentration of tryptophan in the plasma. Tryptophan is an essential amino acid that plays a crucial role in various bodily functions, including the synthesis of serotonin, a neurotransmitter important for mood regulation, and melatonin, which regulates sleep. This test is particularly useful for identifying abnormalities in tryptophan levels, which can be indicative of nutritional deficiencies, metabolic disorders, or certain psychiatric conditions.
Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test offers precise and reliable results. The cost of the Tryptophan Quantitative Plasma Test is set at 2010 AED, reflecting the advanced technology and expertise required to accurately assess tryptophan levels. This test is a valuable tool for healthcare providers in diagnosing and managing conditions related to amino acid imbalances, guiding nutritional therapy, and monitoring the effectiveness of treatment plans.
The Autogen Panel Test, available at DNA Labs UAE for a cost of 2010 AED, is a comprehensive genetic screening designed to analyze an individual's DNA for various genetic markers that could indicate susceptibility to certain diseases or conditions. This state-of-the-art test is performed using a small sample of the individual's blood or saliva, which is then meticulously analyzed in the lab using advanced genomic technologies. The Autogen Panel Test is aimed at providing insights into genetic predispositions, enabling individuals to make informed decisions about their health and lifestyle. By identifying potential genetic risks early, it allows for preventive measures, personalized healthcare planning, and a better understanding of one's genetic makeup. DNA Labs UAE, with its cutting-edge facilities and expert team, ensures accuracy and confidentiality in the test results, making the Autogen Panel Test a valuable tool in the pursuit of personalized medicine and health optimization.
The Episodic Ataxia Type 1 Hotspot Test is a specialized genetic test offered by DNA Labs UAE, designed to diagnose Episodic Ataxia Type 1 (EA1), a rare neurological disorder characterized by sudden, brief episodes of ataxia (lack of muscle coordination) along with other potential symptoms such as muscle twitching and dizziness. This condition is caused by mutations in the KCNA1 gene, which plays a critical role in regulating potassium channels in the brain, essential for maintaining the normal function of nerve cells.
The test specifically targets known mutation hotspots within the KCNA1 gene, providing a focused approach to diagnosing this complex condition. By analyzing the patient's DNA sample, the test can identify mutations associated with EA1, thereby facilitating an accurate diagnosis. This is crucial for the management and treatment of symptoms, as well as for genetic counseling purposes.
DNA Labs UAE offers this cutting-edge genetic test for a cost of 1990 AED. The test represents a significant advancement in the field of genetic diagnostics, providing patients and their families with critical information about EA1 and contributing to a better understanding of the condition's underlying genetic basis. With a commitment to accuracy and reliability, DNA Labs UAE ensures that individuals undergoing the Episodic Ataxia Type 1 Hotspot Test receive comprehensive support and detailed results, paving the way for informed healthcare decisions.
The "Episodic Ataxia Type 2 Hotspot Test" is a specialized genetic screening designed to identify mutations associated with Episodic Ataxia Type 2 (EA2), a rare, inherited neurological disorder characterized by episodes of ataxia (lack of muscle coordination), vertigo, and sometimes migraine headaches. EA2 is primarily caused by mutations in the CACNA1A gene, which plays a crucial role in the communication between neurons in the brain.
This test focuses on specific regions, or "hotspots," within the CACNA1A gene that are most commonly associated with the disorder, offering a targeted approach to genetic testing. By analyzing these hotspots, the test can provide crucial information for the diagnosis, management, and treatment planning for individuals showing symptoms of EA2 or those with a family history of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy, confidentiality, and professional analysis. The cost of the Episodic Ataxia Type 2 Hotspot Test is set at 1990 AED, reflecting the specialized nature of the test and the sophisticated technology employed in its execution.
For families and individuals facing the challenges of EA2, this test represents a valuable tool in understanding their genetic background and making informed health decisions.
The Multiple Myeloma Monitoring Panel Test is a comprehensive diagnostic tool designed to assess and monitor the progression or remission of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This specialized test panel includes a variety of assays that evaluate key markers and factors related to the disease, such as monoclonal protein levels, bone marrow function, and other relevant blood cell counts. It is crucial for tailoring patient treatment plans and tracking the effectiveness of therapy over time.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test offers precise and reliable results. The cost of the Multiple Myeloma Monitoring Panel Test is set at 1990 AED. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and confidentiality of test results. This test is an essential resource for healthcare providers managing patients with multiple myeloma, offering critical insights that guide treatment decisions and improve patient outcomes.
The "ALL Panel Deletion/Duplication Detection Test" is a specialized genetic test offered by DNA Labs UAE, designed to identify deletions or duplications in the genome that are associated with Acute Lymphoblastic Leukemia (ALL). This advanced diagnostic tool is crucial for understanding the genetic basis of ALL and can provide valuable information for tailoring patient-specific treatment strategies. The test employs cutting-edge technology to scan the genome for abnormalities that could influence the course of the disease or impact the effectiveness of certain treatments. Priced at 1990 AED, this test represents a significant step forward in personalized medicine, offering hope for more effective management of ALL through targeted therapy options.
The AML PCR Panel AMLETO Inv16 PMLRARA Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect specific genetic mutations associated with Acute Myeloid Leukemia (AML). This test specifically targets the Inv16 (CBFB-MYH11) and PML-RARA gene rearrangements, which are critical markers for diagnosing certain subtypes of AML. Utilizing Polymerase Chain Reaction (PCR) technology, this panel provides a highly sensitive and accurate method for identifying these genetic abnormalities, which can play a crucial role in determining the most effective treatment plan for patients.
The cost of the AML PCR Panel AMLETO Inv16 PMLRARA Test at DNA Labs UAE is 1650 AED. This investment in testing is vital for patients suspected of having AML, as it aids in the quick and precise identification of their disease subtype, facilitating targeted therapy and improving treatment outcomes. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring that patients receive reliable and high-quality diagnostic services.
A Biopsy Breast Modified Radical Mastectomy is a comprehensive surgical procedure aimed at treating breast cancer by removing the entire breast along with the lymph nodes in the axilla (underarm area), while preserving the pectoral muscles. This operation is often recommended when the cancer is too extensive for a lumpectomy (removal of the tumor and a small margin of surrounding tissue) but where the preservation of the chest muscles is still possible, helping to maintain a better post-surgical cosmetic outcome and potentially reducing recovery time.
Following the surgical procedure, the extracted tissue is typically analyzed to assess the presence and extent of cancer. This is where tests such as ER (Estrogen Receptor), PR (Progesterone Receptor), and HER2/neu come into play. These tests are crucial in determining the cancer's characteristics, including its responsiveness to hormonal therapies and targeted treatments.
- **ER and PR Tests:** These tests measure the presence of estrogen and progesterone receptors in the cancer tissue. Cancers that are positive for these receptors (ER+ or PR+) are likely to respond to hormonal therapies, which can be an effective part of the treatment plan.
- **HER2/neu Test:** This test identifies the presence of the HER2 protein on the surface of the cancer cells. HER2-positive cancers are more aggressive but may respond well to targeted therapies designed to inhibit the HER2 protein.
At DNA Labs UAE, the cost for conducting the ER, PR, HER2/neu tests is 1650 AED. These tests are crucial for tailoring the most effective treatment plan post-mastectomy, offering a personalized approach to breast cancer care. DNA Labs UAE is equipped with state-of-the-art facilities and experienced professionals to ensure accurate and reliable test results, aiding in the optimal management and treatment of breast cancer.
DiGeorge Syndrome, also known as 22q11.2 deletion syndrome, is a disorder caused by a defect in chromosome 22, which results in poor development of several bodily systems. This genetic condition can lead to a range of health issues, including heart defects, immune system problems, facial anomalies, and developmental delays. Early detection and intervention are crucial for managing the symptoms and improving the quality of life for those affected.
To diagnose DiGeorge Syndrome, two main genetic tests are employed: Karyotyping and Fluorescence In Situ Hybridization (FISH) test. Karyotyping is a laboratory procedure that provides a comprehensive view of an individual's chromosomes to identify any large-scale genetic abnormalities, including the deletion characteristic of DiGeorge Syndrome. However, because the deletion in chromosome 22 that causes DiGeorge Syndrome can be very small, a more precise test, known as the FISH test, is often used to confirm the diagnosis. The FISH test is a molecular cytogenetic technique that uses fluorescent probes to visualize specific parts of chromosomes, allowing for the detection of the microdeletion on chromosome 22 associated with the syndrome.
In the UAE, DNA Labs offers these crucial genetic tests for diagnosing DiGeorge Syndrome. The cost of undergoing the testing process is 1650 AED. Conducted in a state-of-the-art facility, DNA Labs UAE ensures accurate and reliable results, providing essential information for the management and treatment of individuals with DiGeorge Syndrome.
